Cancer Flashcards
Effective screening programme
Affordable for the healthcare system
Acceptable to all social groups
Reduce mortality from cancer
Good discriminatory index between benign and malignant lesions
How do pt with cancer present
Screening programmes
Recent change in symptoms ie wt loss, lump, change in bowel habit
Age > 75y/o common to A/E
Local spread of cancer
Nearby tissue often causes compressive/obstructive problems
Distant spread of cancer
Metastasis from initial to 2ndary site commonly lymph nodes, brain, liver, bones and lung
Lymphatic, haematogenous and transcolemic
Lymphatic spread
Comment route of metastasis can lead to haematogenous spread as the thoracic duct drains into the IVC. Lymphadenopathy can = pain due to obstruction/swelling
- ENT = facial/neck lymphadenopathy
- Gastric, oesophageal and breast to axillary and L supraclavicular
- Testicular and ovarian to paraaortic
- Vulval, scrotal and vaginal to femoral/inguinal
Transcolemic spread
Spreads throughout the peritoneum in the circulating peritoneal fluid. Passes up the L paracolic gutter, across surface of the liver and diaphragm and down the omentum
Haematogenous spread
Via the blood spreads rapidly usually venous flow as narrower walls are easier to penetrate
Government targets for cancer
2wk wait - Any GP can refer suspicious red flag symptoms for investigation
31 day limit - 1st treatment must start within 31 days of agreement with pt
62 day limit - Treatment must begin within 62 days of referral
Common PC of cancer
Ascites - ovarian, gastric, pancreatic, HCC
Change in bowel - CRC, prostate, ovary
Dysphagia - Oesophageal, gastric, lung
#’s = 1 sarcoma, mets from renal,thyroid, lung, prostate and breast
Jaundice - HCC, cholangiocarcinoma,
Cancer of unknown primary
Tumor is able to metastasis before the primary site can be identified. Tends to be aggressive, disseminate early and be unpredictable. 5-10% of all cancers
Cause of CUP
i) Squamous cancer usually arising from head and neck/lung. Usually respond well
ii) Poorly differentiated or anaplastic - high grade lymphomas or germ cell tumours respond well treatment
iii) Adenocarcinomas poor prognosis usually pancreas or lung
CUP Mx
Speak to oncologist. Search for a site! You must rule out potentially curable tumors = germ cell!!
CXR, CT chest abdo pelvis, rectal USS = prostate, mammogram = breast
Use tumor markers, full examination PV and testicular
Poor prognosis of CUP
Adenocarcinoma on histology Hepatic/renal involvement Poor performance status >10% wt loss Supraclavicular lymph node involvement High tumor marker levels
Cytological grading
C1 = inadequate for testing C2 = normal morphology C3 = cells abnormal but likely to benign C4 = highly suspicious of cancer C5 = Cancer cells present
Empyema
pH <7.2, low glucose, high WCC + present on culture/microscopy
Transudate vs Exudate
Transudate = protein <3g/l = cirrhosis, HF, renal failure and meigs syndrome
Exudate = protein >3g/L due to infection, inflammation (RA,SLE), PE or cancer.
Pleural albumin : serum albumin >0.5
Pleural LDH : Serum LDH >0.6
Hypercalcemia
Common complication of malignancy seen in 40% of pt
PC - non specific, renal failure, bone pain, confusion, conspitation
Due to either direct invasion of bones - mets, myeloma or squamous cell producing PTHrp
Confusion in cancer pt
Brain mets, hypercalcemia, constipation - bowel obstruction, infection, opiod OD, metabolic disturbance
Mx CUP
Curative treatment = survival
Palliative = QoL, secondary objective - duration of life
Factors influencing decision = pt choice, age, performance status, organ impairment
Smoking
Linked to 90% of lung cancer. Also increases the incidence of oesophageal, laryngeal, bladder, cervical and breast cancer
Asbestos
Causes malignant mesothelioma, potentiates risk of lung cancer if smoker
Amines in dye/rubber
Bladder cancer
Benzene
Myeloid leukaemia
Ionising radiation
BM, breast and thyroid all very sensitive
BCC vs SCC
BCC = shiny, pearly nodule with rolled edge +/- umbilicate centre and telangiectasia
SCC = hyperkeratotic, crusting ulcerated lesion
Both present @ sites of sun exposure - ears, nose corner of mouth. Only definitive diagnosis is to excise
Xeroderma pigmentosum
Rare autosomal recessive condition at NER DNA mismatch repair gene, unable to repair DNA damaged by UV light
PC: severe sunburn with minimum sunlight often from 6month to 3yrs. Photosensitivity and dry skin. Premature skin ageing, increased risk of BCC,SCC and melanoma.
Viral carcinogens
EBV - Burkitt’s and Hodgkins lymphoma craniopharyingoma,
HBV/HCV - HCC
HPV - cervical and oral cancer
HHV-8 = Kaposi and Castlemans
Parasitic carcinogens
H.pylori - gastric cancer and gastric lymphoma
Bilihartzia - Bladder cancer
Liver flukes - cholangiocarcinoma
Schitsomasis - Bladder cancer
Germline vs Somatic
Germaine present at embryogenesis so all cells in the body possess the mutation. Can be passed on to offspring
Somatic mutations acquired during life. Only affects cells they arose from and their subsequent descendants. Cannot be passed to offspring
Process of carcinogenesis
Proliferation in the absence of growth factors, failure to respond to inhibition to proliferation. Evade apoptosis replicative immunity. Angiogenesis and metastasis.
AD cancer syndromes
50% chance of passing to offspring. Lynch syndrome, BRCA I and II, Peutz Jeghers, von hippel lindau, Rb, NF1, MEN1 and 2, Li fraumeni
Peutz Jeghers
Development of multiple haemartous polyps in the GI tract. These are benign and have a low index of malignancy but increase the risk of intussception and CRC
They also have hyperpigmented macules on lips, oral mucosa and palms/soles
Increased risk of liver, lung, ovarian, breast and testicular cancer
MEN 1
AD mutation in the MEN1 gene which gives risk to pancreatic tumours, parathyroid hyperplasia and pituitary adenoma
MEN 2A and 2B
Gain in function mutation in RET gene
2A = medullary thyroid cancer, parathyroid hyperplasia and phaechromocytoma
2B = medullary thyroid cancer, phaechromocytoma, Marfanoid body habitus and multiple mucosal neuromas @ tongue eyelids
Li Fraumeni
Gene mutation in p53 guardian of the genome leads to leukaemia + lymphoma, premenopausal breast cancer, childhood sarcoma and brain tumour. Penetrance 50% by 50y/o
Ataxia telengestasia
AR mutation in AT gene leading loss of DNA repair. High risk of leukaemia, lymphoma and brain malignancy
PC - ataxia in childhood, slurred speech, telangiectasia over sclera of the eyes, FTT and recurrent URTI
Von hippel lindau
Phaechromocytoma, RCC and hemangioblastomas. Common to have problems with eye sight
NF1
PC 6+ cafe au last spots, freckling in axilla, multiple dermal neurofibrotomas, Lisch nodules in the iris - optic gliomas. Reduced IQ, scoliosis and risk of leukaemia and plexiform neurofibromas
NF2
Rare hearing loss, few cutaneous signs, VIII problems
100% have CNS lesions - bilateral vestibular schwannomas, meningiomas
Sensitivity
Ability to pick up all the people that have the disease, i.e. high power to rule out the condition
- True positive = TP - FN
Specificity
Ability to rule out the disease in all those without disease. Ie is specific to only those with the disease so high power to rule in
- True negative = TN + FP
Breast cancer screening
All women 50-70 y/o invited for 3yrly mammogram. Suspicious feature such as soft tissue density or micro calcification = recall
Breast cancer screening for susceptible
Women with BRCA1/2 yearly MRI from 30y/o
FHx - mammograms from 40y/o
Li-fraumeni - yearly MRI from 20y/o
CRC screening
FOB testing 2 yearly from 60-74y/o. Trial of one off flexisigmoidoscopy @ 55y/o
CRC screening for susceptible
IBD = 10 yearly flexisigmoidoscopy Lynch = 2 yearly colonoscopy from 25y/o or 5 years before age of onset in youngest family member FAP = yearly colonoscopy
Cervical cancer
24-49 = 3yrly, 50-64 = 5yrly. Detection of CIN. Doesn’t detect adenocarcinoma which is responsible for 15% of cervical cancer.
Cancer prevention
Vaccination - HBV, HCV and HPV
Dietary measures - increased fibre, low red meat, stop smoking, reduced alcohol public health campaigns
Screening programmes
NSAID’s - protective against cancer approx 7% reduced rate, but no survival benefit due to GI bleed
Tamoxifen - preventing of breast cancer but increases risk of endometrial.
Lung Cancer epidemiology
Peak incidence 60-70y/o, smoking and asbestos exposure increase risk, 3x incidence in males, 5x increased risk if +ve FHx
PC lung cancer
Can be asymptomatic and look like a gradual worsening of COPD - crucial to look as these ppl are most @ risk
PC - progressive SOB, chest pain, change in cough - 3wks long = CXR, anorexia, fatigue, wt loss, fever +/- haemoptysis
May have symptoms of extrinsic compression dysphasia, SVC obstruction, hoarseness of voice due to recurrent laryngeal nerve involvement or symptoms of metastasis
O/E lung cancer
Hands - clubbing, tar staining,
Cachexia, wt loss, SOB @ rest
Axillar or supraclavicular lymphadenopathy
Pleural effusion or lung collapse
Lung cancer spread
Spread often along bronchus of origin. Involves lymphatics 1st to ipsilateral peribronchial and hilar nodes then to mediastinal, contralateral hilar and supraclavicular.
Disseminates into blood stream where it often metastases to the brain, bone and liver
Pancoasts syndrome
Caused by a lung cancer @ apex of the lung. It can grow into the chest wall causing compression of structures
Dependent on the extent of growth can =
Horners syndrome a triad of miosis, ptosis and enopthalmus +/- anhydrosis depend of site. This is due to compression of the sympathetic chain
Severe shoulder pain and atrophy of hand muscles if T1 nerve root is compressed
Can also give phrenic palsys, SVC obstruction and recurrent laryngeal damage
Horners syndrome
With or without anhydrosis depends on the site of the lesion
i) Central causes - anhydrosis of the face, arm and trunk = MS, brain tumors, syringomyalyia
ii) Preganglionic - anydrosis of face only = Pancoast, thyroid carcinoma, goitre
iii) Post ganglionic = no anhydrosis = carotid artery dissection, cavernous sinus thrombosis, migraine
PC of pleural effusion
Tachypnoea, pleuritic chest pain, SOB
O/E - dull to percussion, reduced expansion and breathe sounds, vocal resonance reduced
Inv = exudative effusion if cancer, CXR = meniscus fluid level present, Lights analysis
Types of lung cancer
i) Small cell
ii) Non small cell lung cancer (NSCLS)
Adenocarcinoma, Large cell and squamous
Small cell lung cancer
20% of lung cancers. Carry the worst prognosis aggressive, low doubling time and metastasize early.
Arise from neuroendocrine cells therefore give rise to paraneoplastic syndromes such as SIADH, ectopic ACTH and LEMS
Located centrally often with bulky hilar and mediastinal lymphadenopathy
Adenocarcinoma
40% now the most common lung cancer in UK, lowest smoking link, increased in asbestos exposure.
Originates from mucus secreting glandular cells, originates peripherally in the lung so commonly involves the pleura = pleural effusions
Metastasises to pleura, lymph nodes, brain, bone and adrenals
Squamous cell
Central obstructive lesion of the bronchus can cavitate. Grow slowly, spread locally and disseminate late.
Can give paraneoplastic effects of clubbing, PTHrp and HOA
Large cell
Often peripheral mass poorly differentiated. Grow rapidly and metastasise early. Derived from mucus cell most linked to asbestos
Malignant mesothelioma
Caused by light asbestos exposure. CXR shows tumour arising from serosal cells of the pleura. No cure